Age-Related Macular Degeneration Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The r ...

The European Commission has cleared the high-strength formulation of Eylea (aflibercept) with an extended treatment interval ...

Biocon Biologics secures Health Canada approval for Yesafili, the first biosimilar to Eylea® in Canada, with a global launch ...

CHENNAI: Biocon Biologics, the biosimilars subsidiary of Biocon Ltd, said on Friday that Health Canada has granted a Notice ...

Chinese researchers have suggested that drinking the beverage may lead to a seven-fold higher risk of deteriorated or blurred ...

FYB203 has been approved by the US FDA and UK Medicines and Healthcare products Regulatory Agency for the treatment ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Partnership will introduce Hadley services to Notal Vision patients Winnetka, Illinois--(Newsfile Corp. - June 24, 2025) - ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage ...